Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a dutch compassionate use program

Additional Metadata
Keywords	Myeloma, Refractory, Relapse, Stem cell transplantation, Thalidomide resistance
Persistent URL	doi.org/10.3816/CLML.2010.n.020, hdl.handle.net/1765/83402
Journal	Clinical Lymphoma, Myeloma and Leukemia
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Kneppers, E., Lokhorst, H., Eeltink, C., Huls, G., Kersten, M. J., Koedam, J., … Zweegman, S. (2010). Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a dutch compassionate use program. Clinical Lymphoma, Myeloma and Leukemia, 10(2), 138–143. doi:10.3816/CLML.2010.n.020

Publication